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transplantation. The medical and scientific activities of
Spanish nephrologists related to kidney transplantation have
been very important for many years, and the S.E.N. must
direct, stimulate and lead this activity.
2. EXPLICIT DEFINITION OF OBJECTIVES (GENERAL
AND SPECIFIC) TO COVER
SENTRA’s main purpose is to promote access to kidney
transplantations to patients with advanced chronic kidney
disease and advance in the care of kidney transplanted
patients. Specifically, the activities will focus on:
 Promoting activities of high scientific interest in the
generation of evidence and value in the area of kidney
donation and kidney transplantation: clinical trials,
observational studies, systematic revisions, guidelines
and recommendations.2
 Promoting first class training activities that focus on
kidney transplantation learning for nephrologists, both in
the context of the annual S.E.N. Conference and in other
meetings, as well as through its online platform.
 Extending, both to nephrologists and other health
professionals and society in general, initiatives to overcome
barriers, inequalities, and ethical issues and in general,
anything that might prevent more extensive access with the
best possible results in renal transplant both from living and
deceased donors in all their possible forms.3
T he Board of Directors of the Spanish Society of Nephrol-ogy (S.E.N.) approved at its ordinary meeting of 18 De-cember 2012 the creation of a Transplantation Working
Group (SENTRA). In accordance with the Regulations of the
S.E.N. Working Groups, in promoting the establishment of a
working group, four priority aspects1 must be addressed:
1. GENERAL SCIENTIFIC INTEREST, MEDICAL
INTEREST AND HEALTH INTEREST OF THE ISSUE
PROPOSED FOR STUDY
More than half of patients with advanced chronic kidney 
disease requiring replacement therapy in Spain are kidney
transplantation patients, and as such, it is unquestionable that
transplants are a priority work and knowledge generation
area for all nephrologists. Therefore, the Society must
enhance initiatives that focus on the transplant area, not only
because of its importance as a form of renal replacement
therapy for the patient and its position as the most cost-
efficient technique that provides the best quality of life, but
also because of Spain’s leading global position in
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 Improving collaboration between S.E.N. members,
other S.E.N. working groups and other scientific
societies related to kidney transplantation, mainly the
Spanish Society of Transplantation, the Spanish Society
of Immunology, the Spanish Association of Urology
and its Transplantation Working Group, the European
Dialysis and Transplantation Association and its
Transplantation Working Group, the European Society
for Organ Transplantation, the American Society of
Nephrology, the American Society of Transplantation
and the Transplantation Society.
 Serving as a representative, always by mandate and
delegation of the S.E.N. Board of Directors in matters
related to transplantation that are of interest to the
members, in their relationship with bodies such as the
National Transplant Organization, as well as with other
Administrative and social agents.
The first attempt of Spanish nephrologists to work in the
field of evidence-based medicine at an institutional level in
S.E.N. was the creation of its Kidney Transplantation
Evidence-based Medicine Group in 2001, coordinated by
Julio Pascual, whose objective was to share these tools and
carry out systematic revisions.3-6 This group definitively
joined that which was subsequently created in evidence-
based medicine in nephrology, coordinated by Carlos
Quereda.7,8 The group focuses on the generation of
knowledge in all areas of Nephrology and publishes
reviews, methodological commentaries and structured
abstracts, currently in the supplements of Evidence-based
Nephrology.9,10 SENTRA will actively collaborate in these
type of activities.
In recent years, various professional groups have joined
forces to generate initiatives and knowledge in the area of
transplantation in Spain. In the 1990s, led by José M.
Morales, a first S.E.N. Renal Transplant group was created,
which carried out major collaborative activities during that
decade. Subsequently, the Renal Forum groups, sponsored
by Astellas, were developed and continue to be productive,11,
12 as well as the Chronic Nephropathy Transplant Group,
sponsored by Wyeth and coordinated by Daniel Serón, which
since its inception has produced some of the studies and
publications of most interest and impact carried out by
Spanish renal transplant nephrologists.13-17 In 2000, ATOS
(Solid Organ Transplant Clinic) was created. It is sponsored
by the company Roche and includes Spanish experts in
transplantation of various solid organs who meet annually to
disseminate knowledge on the most diverse topics related to
this area, whose scope goes beyond kidney transplantation.
In recent years, and before the creation of the Spanish
Society of Transplantation, it was the most stable tool for
collaboration between transplant professionals of various
bodies.18 In an attempt to analyse the evidence available
regarding the metabolic disorders after renal transplant and
reach a consensus over their management, the Prometheus
Group, was established in 2007, also sponsored by Roche,
which includes a renal transplant nephrologist for each
Transplantation Unit of our country and which is coordinated
by Dr Manuel Arias and Dr Josep M ª Campistol.19,20 The
group meets annually after continuous work on a particular
topic and is advised by non-nephrologist experts and
specialists in evidence-based medicine. The Spanish Group
in Transplantation Actions (GREAT), which was established
in 2006 and is coordinated by Sofía Zárraga and Ana
Sánchez-Fructuoso and sponsored by the company Astellas
is developing collaborative projects of special interest and
international impact.21,22 SENTRA, as an official S.E.N.
Working Group, as well as developing its own strategy, will
facilitate the development of open projects that can be
generated within all of these collaborative groups, with the
aim of integrating and complementing, in compliance with
the institutional objectives of the S.E.N.
3. ESTABLISHMENT OF A DETAILED ACTION PLAN
THAT INCLUDES MEANS TO BE USED, RESOURCES
AVAILABLE AND THE ACTION SCHEDULE
During the first months of 2013, a SENTRA development
process will begin: firstly its coordinating committee will be
established (two coordinators and eight additional members),
who will meet to design the action plan, targets and
schedule. SENTRA will immediately be open to all members
who are interested in taking part in it; the only requirement is
to be members of the S.E.N. and after having made a
declaration of interest to participate in the activities and
initiatives of the group. The SENTRA coordinating
committee will initiate fluid communication immediately
with members of the S.E.N. to facilitate their incorporation
into the group and its activities, at various levels of
commitment that its members establish freely in each case.
4. NO CONFLICT OF INTEREST WITH OTHER
WORKING GROUPS OF THE S.E.N.
Although it has been said that in Spain there are various
collaborative groups working in the area of kidney
transplantation, there is no similar institutional operating
group in the Society that is open to 100% of its
members.
In accordance with the Regulations for creating working
groups, “the Board of Directors will determine the
appointment of the members of each working group
from among the S.E.N. members who voluntarily decide
to join and participate in it. With this aim, the Board of
Directors will be guided by the sole criterion that the
elected members possess an unquestionable professional
and scientific career in the relevant area of the working
group.”1 SENTRA’s initial coordinators are Drs Josep Mª
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Cruzado and Julio Pascual, and its coordinating
committee is completed by Drs Ángel Alonso, Fritz
Diekmann, Roberto Gallego, Domingo Hernández, Álex
Gutiérrez-Dalmau, José M. Morales, Emilio Rodrigo and
Sofía Zárraga. As has already been mentioned, all
members of SENTRA must be members of the S.E.N. to
register as such. The coordinating committee will meet by
teleconference at least once every 3 months and in person
at least once a year, in order to promote the targets
proposed. This arrangement will remain in place for 3
years and in June 2016, one of the coordinators will be
replaced along with four members of the coordinating
committee, and in June 2019, the remainder, in order that
the total renewal occurs in 6 years.
SENTRA will have a website to develop its outreach,
communication and training activities and will work
closely with the Board of Directors, the Senefro
Foundation, the grupo editorial Nefrología and the
Technical Secretary of the S.E.N.
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